These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3826485)

  • 21. Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.
    Basu A; Chakrabarti G; Saha A; Bandyopadhyay S
    Immunology; 2000 Feb; 99(2):305-13. PubMed ID: 10692051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two new techniques for quantitative determination of Leishmania amastigotes.
    Cenini P; Reeve AM; Neal RA
    Trans R Soc Trop Med Hyg; 1989; 83(2):194-5. PubMed ID: 2609370
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellular mediators in human leishmaniasis: Critical determinants in parasite killing or disease progression.
    Divenuto F; Marascio N; Quirino A; Giancotti A; Filice S; Gigliotti S; Campolo MP; Campolo M; Barreca GS; Lamberti AG; Castelli G; Bruno F; Matera G
    Acta Trop; 2023 Dec; 248():107037. PubMed ID: 37805040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visceral leishmaniasis: a difficult diagnosis and unusual causative agent.
    Oren R; Schnur LF; Ben Yehuda D; Mayner V; Okon E; Rachmilewitz EA
    J Infect Dis; 1991 Oct; 164(4):746-9. PubMed ID: 1654358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
    Rostamian M; Jafari D; Abolghazi M; Farahani H; Niknam HM
    Parasitol Res; 2018 Sep; 117(9):2949-2956. PubMed ID: 29978420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease.
    Lira R; Méndez S; Carrera L; Jaffe C; Neva F; Sacks D
    Exp Parasitol; 1998 Jul; 89(3):331-42. PubMed ID: 9676711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Eco-epidemiology of visceral and cutaneous leishmaniasis in the Arab Republic of Yemen. II. A survey using intradermal reaction to leishmanin in a zone of mixed infestation with Leishmania tropica, L. donovani and L. infantum].
    Dereure J; Rageh HA; Daoud W; Rioux JA
    Bull Soc Pathol Exot Filiales; 1989; 82(5):665-8. PubMed ID: 2633875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
    Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
    Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania.
    Nandan D; Zhang N; Yu Y; Schwartz B; Chen S; Kima PE; Reiner NE
    PLoS One; 2018; 13(11):e0206920. PubMed ID: 30399177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of five selective media for the primary isolation of Leishmania strains in India.
    Ghosh AK; Ghosh DK; Bhattacharya A; Das P
    Trop Med Parasitol; 1987 Sep; 38(3):187-90. PubMed ID: 3432954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leishmania braziliensis in the squirrel monkey: development of primary and satellite lesions and lack of cross-immunity with Leishmania donovani.
    Lujan R; Chapman WL; Hanson WL; Dennis VA
    J Parasitol; 1990 Aug; 76(4):594-7. PubMed ID: 2380874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermal and visceral leishmaniasis and their causative agents.
    Lainson R; Shaw JJ; Silveira FT
    Trans R Soc Trop Med Hyg; 1987; 81(4):702-3. PubMed ID: 3445360
    [No Abstract]   [Full Text] [Related]  

  • 34. Axenic cultivation of amastigotes of Leishmania donovani and Leishmania major and their infectivity.
    al-Bashir NT; Rassam MB; al-Rawi BM
    Ann Trop Med Parasitol; 1992 Oct; 86(5):487-502. PubMed ID: 1288430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection.
    Anstead GM; Chandrasekar B; Zhao W; Yang J; Perez LE; Melby PC
    Infect Immun; 2001 Aug; 69(8):4709-18. PubMed ID: 11447142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xenodiagnosis of Leishmania donovani in BALB/c mice using Phlebotomus orientalis: a new laboratory model.
    Sadlova J; Seblova V; Votypka J; Warburg A; Volf P
    Parasit Vectors; 2015 Mar; 8():158. PubMed ID: 25881258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a Leishmaniadonovani nucleotide sugar transporter in Leishmaniamajor enhances survival in visceral organs.
    Zhang WW; Chan KF; Song Z; Matlashewski G
    Exp Parasitol; 2011 Dec; 129(4):337-45. PubMed ID: 21978449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginase Is Essential for Survival of Leishmania donovani Promastigotes but Not Intracellular Amastigotes.
    Boitz JM; Gilroy CA; Olenyik TD; Paradis D; Perdeh J; Dearman K; Davis MJ; Yates PA; Li Y; Riscoe MK; Ullman B; Roberts SC
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
    Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
    Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.